Evidence map›Paper›PMID 33932034›Full record

ArticleThe EMBO journal2021

BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis.

Mónica Vara-Pérez, Matteo Rossi, Chris Van den Haute, Hannelore Maes, Maria Livia Sassano, Vivek Venkataramani, Bernhard Michalke, Erminia Romano, Kristine Rillaerts, Abhishek D Garg and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Mitochondrial bioenergetics and networks in melanoma: an update.Apoptosis : an international journal on programmed cell death · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mitochondrial Reactive Oxygen Species (mROS) Generation and Cancer:International journal of nanomedicine · 2025
    Review
  19. Joint estimation of compartment-specific TMagnetic resonance in medicine · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Mónica Vara-PérezCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0001-6196-4696
Matteo RossiVIB Center for Cancer Biology Research, Leuven, Belgium.
Chris Van den HauteResearch Group for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Hannelore MaesCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Maria Livia SassanoCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Vivek VenkataramaniInstitute of Pathology, University Medical Center Göttingen (UMG), Göttingen, Germany.ORCID 0000-0002-6771-365X
Bernhard MichalkeHelmholtz Zentrum München GmbH - German Research Center for Environmental Health, Research Unit Analytical BioGeoChemistry, Neuherberg, Germany.
Erminia RomanoCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Kristine RillaertsCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Abhishek D GargCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Corentin SchepkensLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
Francesca M BosisioLaboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Jasper WoutersLaboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Ana Isabel OliveiraVIB Center for Cancer Biology Research, Leuven, Belgium.
Peter VangheluweLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-7822-2944
Wim AnnaertLaboratory for Membrane Trafficking, Department of Neurosciences, KU Leuven, Leuven, Belgium.ORCID 0000-0003-0150-9661
Johannes V SwinnenLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
Jean Marie ColetHuman Biology and Toxicology Unit, University of Mons, Mons, Belgium.
Joost J van den OordLaboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
Sarah-Maria FendtVIB Center for Cancer Biology Research, Leuven, Belgium.
Massimiliano MazzoneVIB Center for Cancer Biology Research, Leuven, Belgium.ORCID 0000-0001-8824-4015
Patrizia AgostinisCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0003-1314-2115
VIB-KU Leuven Center for Cancer Biology · BEKU Leuven · BEUniversity of Mons · BEHelmholtz Zentrum München · DEUniversitätsmedizin Göttingen · DEVIB-KU Leuven Center for Brain & Disease Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BNIP3 is a mitophagy receptor with context-dependent roles in cancer, but whether and how it modulates melanoma growth in vivo remains unknown. Here, we found that elevated BNIP3 levels correlated with poorer melanoma patient's survival and depletion of BNIP3 in B16-F10 melanoma cells compromised tumor growth in vivo. BNIP3 depletion halted mitophagy and enforced a PHD2-mediated downregulation of HIF-1α and its glycolytic program both in vitro and in vivo. Mechanistically, we found that BNIP3-deprived melanoma cells displayed increased intracellular iron levels caused by heightened NCOA4-mediated ferritinophagy, which fostered PHD2-mediated HIF-1α destabilization. These effects were not phenocopied by ATG5 or NIX silencing. Restoring HIF-1α levels in BNIP3-depleted melanoma cells rescued their metabolic phenotype and tumor growth in vivo, but did not affect NCOA4 turnover, underscoring that these BNIP3 effects are not secondary to HIF-1α. These results unravel an unexpected role of BNIP3 as upstream regulator of the pro-tumorigenic HIF-1α glycolytic program in melanoma cells.

Indexed as

AnimalsApoptosisCell Line, TumorComputational BiologyFemaleGas Chromatography-Mass SpectrometryHumansHypoxia-Inducible Factor 1, alpha SubunitImmunoblottingImmunohistochemistryMagnetic Resonance SpectroscopyMelanomaMembrane ProteinsMiceMice, Inbred C57BLMitochondrial ProteinsBNip3 protein, mouseHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMembrane ProteinsMitochondrial ProteinsBNIP3ferritinophagyHIF-1αmelanomametabolism

Identifiers

PMID33932034
PMCPMC8126921
OpenAlexW3158823549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.